Medication info

HeraGen Injection

Prescription medication
Ingredient · strength
L-Isoleucine›920mg / 100mLL-Leucine›945mg / 100mLL-Lysine Acetate›395mg / 100mLL-Methionine›44mg / 100mLL-Phenylalanine›30mg / 100mLL-Threonine›214mg / 100mLL-Tryptophan›70mg / 100mLL-Valine›890mg / 100mLL-Alanine›840mg / 100mLL-Arginine›1537mg / 100mLL-Aspartic Acid›20mg / 100mLL-Histidine›310mg / 100mLL-Proline›530mg / 100mLL-Serine›260mg / 100mLL-Tyrosine›40mg / 100mLGlycine›540mg / 100mL
Manufacturer / importer
Wise Medi Co., Ltd.
Appearance
A colorless to pale yellow transparent injection solution in a plastic container for infusion.
Packaging
100mL/bag, 250mL/bag
Approval status
Active

MFDS item code 200600817 · Notified 2006.03.09

Summary

Main use
Improvement of encephalopathy due to chronic liver disease
Who uses it
Adults
Adult dosage
○ Adults: Generally, administer 500 mL per dose by intravenous infusion. ○ Infusion rate: Generally, allow at least 180 minutes per 500 mL in adults. ○ For central venous administration: Mix 500 mL of this medicine with a carbohydrate-containing infusion solution or similar, and continuously infuse it into a central vein over 24 hours. Dosage may be adjusted according to age, symptoms, and body weight.

Ingredients

Manufacturer
Wise Medi Co., Ltd.

Efficacy & effects

Improvement of encephalopathy due to chronic liver disease

  • Encephalopathy caused by chronic liver failure
View approved original text

This medication helps to improve the symptoms of encephalopathy caused by chronic liver failure. It alleviates encephalopathy caused by decreased liver function, contributing to the recovery of the patient's consciousness and neurological function. With this efficacy, we assist patients in returning to normal life.

Dosage and Administration

Adult dosage

○ Adults: Generally, administer 500 mL per dose by intravenous infusion. ○ Infusion rate: Generally, allow at least 180 minutes per 500 mL in adults. ○ For central venous administration: Mix 500 mL of this medicine with a carbohydrate-containing infusion solution or similar, and continuously infuse it into a central vein over 24 hours. Dosage may be adjusted according to age, symptoms, and body weight.

Precautions

This medication must be used according to the instructions of a physician. It should not be administered to patients with severe renal impairment or high blood urea nitrogen levels. Patients with abnormalities in amino acid metabolism beyond liver dysfunction should also avoid its use. It is safer not to administer it to patients with metabolic disorders involving nitrogen utilization, severe heart failure, or pulmonary edema. Patients with very low or absent urine output and those with high sodium or chloride levels should not use this medication. If magnesium is present, it should not be given to patients with heart block or severe myasthenia gravis, and caution is needed for patients with fluid overload. Caution should be exercised in administering it to patients with severe acidosis, heart failure, edema due to sodium retention, or hyperkalemia. Sodium bisulfite included in this medication can cause allergic reactions, especially in asthma patients, potentially triggering asthma attacks. Occasionally, symptoms related to the heart such as skin rash, nausea, vomiting, chest discomfort, and palpitations may occur, and immediate discontinuation should be done if symptoms arise. Rapid administration in large amounts may cause acidosis, so caution is warranted. This medication may also cause serious side effects such as chills, fever, headache, and respiratory distress, so if unusual symptoms occur, patients should consult healthcare professionals immediately. If magnesium is included, peripheral vasodilation may occur, requiring caution. Various metabolic abnormalities, including metabolic acidosis, hypophosphatemia, and hyperglycemia, may arise, necessitating regular testing. Patients with impaired liver or kidney functions should be cautious as blood urea nitrogen levels may increase. Safety has not been established during pregnancy, hence it should only be used when therapeutic benefits outweigh the risks. When administered to children, maintain a lower concentration and frequently check blood ammonia levels. Elderly patients may have reduced body functions, so administration speed should be slow, and dosages should be adjusted. As this medication contains electrolytes, caution is needed regarding electrolyte balance during large doses, and rapid infusion may cause side effects, necessitating slow administration. Strict aseptic conditions must be maintained during administration, and discolored or cloudy solutions should not be used. During storage, the package should not be opened, and products with damaged rubber stoppers should not be used.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • elevated blood pressure
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • respiratory distress
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary tract constriction
  • peripheral vascular dilation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and is best kept at room temperature between 1 to 30 degrees Celsius. This helps to maintain the efficacy of the medication.

Appearance and packaging

Appearance

A colorless to pale yellow transparent injection solution in a plastic container for infusion.

Package unit

100mL/bag, 250mL/bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.